Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients.

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Abstract Text:

James C Oates,Libby W Farrelly,Ann F Hofbauer,Wei Wang,Gary S Gilkeson,James C Oates,Libby W Farrelly,Ann F Hofbauer,Wei Wang,Gary S Gilkeson,

OBJECTIVE: Both increased production of reactive oxygen and nitrogen intermediates (RONI) and reduced levels of complement may play a role in the increased apoptosis and reduced clearance of apoptotic cells in systemic lupus erythematosus (SLE). The objective of this study was to evaluate both processes in a parallel, prospective, longitudinal manner. METHODS: Sixty-seven SLE patients were evaluated during multiple visits, and 31 healthy control subjects were evaluated once or twice. Clinical and laboratory features of SLE disease activity were determined, and blood was collected for measurement of serum nitrate plus nitrite (NOx) levels and for isolation of peripheral blood mononuclear cells (PBMCs). PBMCs were cultured with a nitric oxide (NO) donor and SLE or control plasma, with or without heat inactivation, cobra venom factor (CVF), or lipopolysaccharide plus interferon-gamma treatment. Cells were analyzed for apoptotic index (AI), cellular subsets, and RONI production. RESULTS: The PBMC AI was associated with SLE and was inversely associated with complement levels over time. Changes in the AI with addition of a NO donor was longitudinally associated with serum NOx levels, and stimulation of SLE PBMCs led to parallel increases in RONI production and apoptosis. Addition of SLE plasma resulted in a greater PBMC AI, an effect that was increased with heat inactivation and was corrected with CVF treatment. CONCLUSION: These data suggest that the greater AI observed in SLE PBMCs relates to increased PBMC RONI production and reduced complement levels. The longitudinal nature of these parallel associations within individuals suggests that these processes are dynamic and additive.

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Publishing Authors By Initials

JC Oates,LW Farrelly,AF Hofbauer,W Wang,GS Gilkeson,JC Oates,LW Farrelly,AF Hofbauer,W Wang,GS Gilkeson,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Arthritis and rheumatism

VOLUME: 56

Page Numbers: 3738-47

Journal Abbreviation: Arthritis Rheum.

ISSN: 0004-3591

DAY: 26

MONTH: Nov

YEAR: 2007

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370605

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients.

AFFILIATION: Medical University of South Carolina, Department of Medicine, Division of Rheumatology, Charleston, SC 29425, USA. oatesjc@musc.edu

Country: United States

AGENCY: United States NCRR

GRANT: M01-RR-01070

ACRONYM: RR

MEDLINETA: Arthritis Rheum

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients Related Publications

• Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients.
• Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.
• Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus.
• Autoantibody prevalence and lupus characteristics in a unique African American population.
• Automatic Registration of CT Volumes and Dual-Energy Digital Radiography for Detection of Cardiac and Lung Diseases.
• CT appearance of the pleural space after talc pleurodesis.
• Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage.
• Ethnic disparities among patients with systemic lupus erythematosus in South Carolina.
• Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.
• Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse.
• Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL +/+ mice.
• Regulation of Fli1 gene expression and lupus.
• Remnants of fetal circulation: appearance on MDCT in adults.
• Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus.
• Synergy of MDCT and cine MRI for the evaluation of cardiac motility.
• Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: Mortality risk and quality of life early in the course of disease.